Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (271-280 of 536) with videos related to

Pageof 54
Sort By:
Haematologica|May 13, 2010
Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemiasWilliam Blum, Mitch A Phelps, Rebecca B Klisovic, et al.
British Journal of Haematology|May 12, 2010
Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylationKristie A Blum, Zhongfa Liu, David M Lucas, et al.
Oncoimmunology|October 6, 2018
Daratumumab induces CD38 internalization and impairs myeloma cell adhesionJayeeta Ghose, Domenico Viola, Cesar Terrazas, et al.
Cancers|March 25, 2022
Synergy of Venetoclax and 8-Chloro-Adenosine in AML: The Interplay of rRNA Inhibition and Fatty Acid MetabolismDinh Hoa Hoang, Corey Morales, Ivan Rodriguez Rodriguez, et al.
Blood|March 19, 2005
The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapySusan P Whitman, Shujun Liu, Tamara Vukosavljevic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461Guido Marcucci, Krzysztof Mrózek, Amy S Ruppert, et al.
Blood|December 11, 2012
Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathwayYonghui Li, Li Gao, Xufeng Luo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2007
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3BMuller Fabbri, Ramiro Garzon, Amelia Cimmino, et al.
Cancer Research|March 1, 2005
Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemiaShujun Liu, Tiansheng Shen, Lenguyen Huynh, et al.
Nature Genetics|February 22, 2005
Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemiaLi Yu, Chunhui Liu, Jeff Vandeusen, et al.
Pageof 54

Showing results (271-280 of 536) with videos related to

Sort By:
Pageof 54
Haematologica|May 13, 2010
Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemiasWilliam Blum, Mitch A Phelps, Rebecca B Klisovic, et al.
British Journal of Haematology|May 12, 2010
Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylationKristie A Blum, Zhongfa Liu, David M Lucas, et al.
Oncoimmunology|October 6, 2018
Daratumumab induces CD38 internalization and impairs myeloma cell adhesionJayeeta Ghose, Domenico Viola, Cesar Terrazas, et al.
Cancers|March 25, 2022
Synergy of Venetoclax and 8-Chloro-Adenosine in AML: The Interplay of rRNA Inhibition and Fatty Acid MetabolismDinh Hoa Hoang, Corey Morales, Ivan Rodriguez Rodriguez, et al.
Blood|March 19, 2005
The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapySusan P Whitman, Shujun Liu, Tamara Vukosavljevic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: results from cancer and leukemia group B study 8461Guido Marcucci, Krzysztof Mrózek, Amy S Ruppert, et al.
Blood|December 11, 2012
Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathwayYonghui Li, Li Gao, Xufeng Luo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2007
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3BMuller Fabbri, Ramiro Garzon, Amelia Cimmino, et al.
Cancer Research|March 1, 2005
Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemiaShujun Liu, Tiansheng Shen, Lenguyen Huynh, et al.
Nature Genetics|February 22, 2005
Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemiaLi Yu, Chunhui Liu, Jeff Vandeusen, et al.
Pageof 54